Authors
Shahin Akhondzadeh, Najaf Tahmacebi‐Pour, Ahamad‐Ali Noorbala, Homayoun Amini, Hassan Fallah‐Pour, Amir‐Hossein Jamshidi, Mousa Khani
Publication date
2005/2
Journal
Phytotherapy Research: An International Journal Devoted to Pharmacological and Toxicological Evaluation of Natural Product Derivatives
Volume
19
Issue
2
Pages
148-151
Publisher
John Wiley & Sons, Ltd.
Description
Depression is a serious disorder in today's society, with estimates of lifetime prevalence as high as 21% of the general population in some developed countries. As a therapeutic plant, saffron is considered excellent for stomach ailments and as an antispasmodic, to help digestion and to increase appetite. It is also used for depression in Persian traditional medicine. Our objective was to assess the efficacy of the stigmas of Crocus sativus (saffron) in the treatment of mild to moderate depression in a 6‐week double‐blind, placebo‐controlled and randomized trial.
Forty adult outpatients who met the Diagnostic and Statistical Manual of Mental Disorders, 4th edition for major depression based on the structured clinical interview for DSM IV participated in the trial. Patients had a baseline Hamilton rating scale for depression score of at least 18. In this double‐blind, placebo‐controlled, single‐centre and randomized trial …
Total citations
2006200720082009201020112012201320142015201620172018201920202021202220232024510147182019273228333129222528271813
Scholar articles
S Akhondzadeh, N Tahmacebi‐Pour, AA Noorbala… - … Research: An International Journal Devoted to …, 2005